Literature DB >> 19925962

Novel and improved technologies for tuberculosis diagnosis: progress and challenges.

Madhukar Pai1, Jessica Minion, Hojoon Sohn, Alice Zwerling, Mark D Perkins.   

Abstract

Despite a decade of success in improving cure rates for tuberculosis (TB), diagnosis and case detection remain a major obstacle to TB control. This article reviews the existing evidence base on TB diagnostics, describes the progress of new technologies, and ends with a review of cost-effectiveness and modeling studies on the potential effect of new diagnostics in TB control.

Entities:  

Mesh：

Year:  2009        PMID： 19925962     DOI： 10.1016/j.ccm.2009.08.016

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  46 in total

Review 1.  Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance.

Authors:  Stephen D Lawn; Mark P Nicol
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

2.  High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay.

Authors:  Stephen D Lawn; Andrew D Kerkhoff; Monica Vogt; Robin Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2012-07-01       Impact factor: 3.731

3.  Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.

Authors:  Diane V Havlir; Michelle A Kendall; Prudence Ive; Johnstone Kumwenda; Susan Swindells; Sarojini S Qasba; Anne F Luetkemeyer; Evelyn Hogg; James F Rooney; Xingye Wu; Mina C Hosseinipour; Umesh Lalloo; Valdilea G Veloso; Fatuma F Some; N Kumarasamy; Nesri Padayatchi; Breno R Santos; Stewart Reid; James Hakim; Lerato Mohapi; Peter Mugyenyi; Jorge Sanchez; Javier R Lama; Jean W Pape; Alejandro Sanchez; Aida Asmelash; Evans Moko; Fred Sawe; Janet Andersen; Ian Sanne
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

Review 4.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

5.  Epidemiology of molecular probes in Xpert MTB/RIF assay in Khyber Pakhtunkhwa, Pakistan.

Authors:  Anwar Sheed Khan; Muhammad Tahir Khan; Sajid Ali; Taj Ali Khan; Muhammad Qasim; Arif Malik; Sajid Ali; Wasim Sajjad; Qurrat Ul Ain; Muhammad Irfan
Journal:  Arch Microbiol       Date:  2021-02-27       Impact factor: 2.552

6.  The impact of new tuberculosis diagnostics on transmission: why context matters.

Authors:  Hsien-Ho Lin; David Dowdy; Christopher Dye; Megan Murray; Ted Cohen
Journal:  Bull World Health Organ       Date:  2012-07-16       Impact factor: 9.408

Review 7.  Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Authors:  Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

8.  Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis.

Authors:  Robin Wood; Stephen D Lawn
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

9.  Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.

Authors:  Keertan Dheda; Virginia Davids; Laura Lenders; Teri Roberts; Richard Meldau; Daphne Ling; Laurence Brunet; Richard van Zyl Smit; Jonathan Peter; Clare Green; Motasim Badri; Leonardo Sechi; Surendra Sharma; Michael Hoelscher; Rodney Dawson; Andrew Whitelaw; Jonathan Blackburn; Madhukar Pai; Alimuddin Zumla
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

10.  Newer Diagnostic Tests for Pulmonary Tuberculosis in Children.

Authors:  Rina Triasih
Journal:  Indian J Pediatr       Date:  2015-07-30       Impact factor: 1.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.